WILLIAM MEEK: Open Payments
NPI 1639518301 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 59 payments from 16 companies in 2025. Trend: 2023 $13 · 2024 $1,003 · 2025 $1,590
Food & beverage: $1,526Education: $64
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 8 | $209 |
| Novo Nordisk Inc | 4 | $209 |
| AstraZeneca Pharmaceuticals LP | 4 | $148 |
| PFIZER INC. | 7 | $143 |
| Novartis Pharmaceuticals Corporation | 6 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| Merck Sharp & Dohme LLC | 6 | $109 |
| Lilly USA, LLC | 1 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $89 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $75 |
Products named: UPTRAVI, LOKELMA, LEQVIO, CAPLYTA, Ozempic, ZEPBOUND, Kerendia, Wegovy.
Industry payments across GA — which companies pay providers there.
